| |
|
|
|
Aldeyra Therapeutics Inc.  
|
|
9.33 0.1 (0.01%) |
12-10 16:00 |
|
Open: |
9.43 |
Pre close: |
9.23 |
Target:
|
11.72
|
|
High: |
9.43 |
Low: |
8.9 |
Resistance:
|
10.03
11.35
|
|
Volume: |
237,409 |
Market Cap: |
245M |
Support:
|
7.91
6.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.54
 |
MACD |
MACD(12,26):
|
-0.29 |
|
MA(20): |
9.22  |
Signal(12,26,9): |
-0.42 |
|
MA(100): |
9.40 |
Stochastic Oscillator |
%K(14,3):
|
61.00 |
|
MA(250): |
8.39 |
%D(3): |
63.60 |
|
Average Volume(K) |
3-Month: |
76841
|
52-Week |
High:
|
16.70 |
|
10-Days: |
20419 |
Low: |
6.20 |
|
RSI |
RSI(14):
|
46.36 |
Change(%): |
37.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.780 |
Return on Equity (ttm) |
-94.5 |
Shares Out. (M) |
26.24 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-81.6 |
Shares Float (M) |
25.82 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.00 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
71.70 |
|
Forward EPS |
-2.372 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
9.040 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.24 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.91 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-25.19 |
P/CF |
-9.10 |
|
|
|
|
|
|
